Lynn Schuchter of the School of Medicine comments on a drug treatment that was shown to extend skin-cancer patients’ lives.
Perelman School of Medicine
Oren Friedman of the School of Medicine is interviewed about why several men are opting for cosmetic surgery.
Robert Vonderheide of the School of Medicine leads a study on treating pancreatic cancer.
Researchers at the University of Pennsylvania’s Abramson Cancer Center have discovered a novel way of treating pancreatic cancer by activating the immune system to destroy the cancer’s scaffolding. The strategy was tested in a small cohort of patients with advanced pancreatic cancer, several of whose tumors shrank substantially. The team believes their findings – and the novel way in which they uncovered them -- could lead to quicker, less expensive cancer drug development.